<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03448302</url>
  </required_header>
  <id_info>
    <org_study_id>CTPCRCICWTG</org_study_id>
    <nct_id>NCT03448302</nct_id>
  </id_info>
  <brief_title>Computed Tomography Perfusion Colorectal Cancer With Tumor Grade</brief_title>
  <official_title>Computed Tomography Perfusion of Colorectal Cancer in Correlation With Tumor Grade</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Colorectal cancer is the third most commonly diagnosed cancer in the world. The 5-years
      survival rate depends on the tumor stage and grade at patient presentation. Individual
      treatment strategy based on the tumor stage and grade should be applied to improve the
      prognosis, So the pre-operative diagnostic evaluation and grading of colorectal cancer are
      important.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Diagnosis of cancer colon is usually based on colonoscopy which provides direct visualization
      of the lesions and allows for biopsies. However the pre-operative specimens from endoscopic
      biopsies sometimes fail to grade tumor because of the lack of sufficient tissue. Recent
      improvements in computed tomography have allowed for minimally invasive evaluation of cancer
      colon. Quantitative iodine density measurement can be used to differentiate low and high
      grade colorectal cancer. However, debate continues regarding the correlation between tumor
      grade and computed tomography perfusion parameters of colorectal cancer demonstrating the
      need for further investigation in this area of research.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 10, 2018</start_date>
  <completion_date type="Anticipated">July 10, 2019</completion_date>
  <primary_completion_date type="Anticipated">March 10, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Blood flow of tumor</measure>
    <time_frame>One month</time_frame>
    <description>Accuracy of blood flow of the tumor in prediction of tumor grade in correlation with histopathological results</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood volume of the tumor</measure>
    <time_frame>One month</time_frame>
    <description>Accuracy of blood volume of the tumor in prediction of tumor grade in correlation with histopathological results</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean transient time of the tumor</measure>
    <time_frame>One month</time_frame>
    <description>transient time of the tumor in prediction of tumor grade in correlation with histopathological results</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Permeability surface of the tumor</measure>
    <time_frame>One month</time_frame>
    <description>Accuracy of permeability surface of the tumor in prediction of tumor grade in correlation with histopathological results</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Colo-rectal Cancer</condition>
  <arm_group>
    <arm_group_label>Patients with colorectal adenocarcinoma</arm_group_label>
    <description>The patients will undergo computed tomography perfusion</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Computed tomography perfusion</intervention_name>
    <description>Pre-contrast images will be obtained to identify the colorectal tumor location. Then Fifty milliliters of iopromide (Ultravist ) will be injected intra-venously at rate of 5 milliliter per second via an automatic pump injector for computed tomography perfusion scans. Computed tomography perfusion scans will be performed at the mid-portion of the tumor for 60seconds beginning 5 seconds after contrast injection. Then arterial input will be defined by using the mouse to place a circular region of interest and the tumor region of interest will be placed on the most enhanced area of the tumor. Tumor blood flow, blood volume, mean transient time &amp; permeability surface measurements will be obtained.</description>
    <arm_group_label>Patients with colorectal adenocarcinoma</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with colorectal mass pathologically proved to be adenocarcinoma by colonoscpoic
        biopsy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any patient with primary colorectal mass

        Exclusion Criteria:

          -  Colorectal mass pathologically proved to be benign Female patient at child bearing
             period with suspected pregnancy Raised renal chemistry Hypersensitivity to contrast.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter E Megala, MBBCh</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Afaf A Hassan, MD</last_name>
    <phone>01095229303</phone>
    <email>Drafaf.kader@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mostafa A El-Sharkawy, MD</last_name>
    <phone>01223971443</phone>
    <email>drmostafamri@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Faculty of Medicine</name>
      <address>
        <city>Assiut</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Afaf A Hassan, MD</last_name>
      <phone>01095229303</phone>
      <email>Drafaf.kader@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Mostafa A ElSharkawy, MD</last_name>
      <phone>01223971443</phone>
      <email>drmostafamri@yahoo.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Sun H, Xu Y, Yang Q, Wang W. Assessment of tumor grade and angiogenesis in colorectal cancer: whole-volume perfusion CT. Acad Radiol. 2014 Jun;21(6):750-7. doi: 10.1016/j.acra.2014.02.011.</citation>
    <PMID>24809317</PMID>
  </reference>
  <reference>
    <citation>Kim JW, Jeong YY, Chang NK, Heo SH, Shin SS, Lee JH, Hur YH, Kang HK. Perfusion CT in colorectal cancer: comparison of perfusion parameters with tumor grade and microvessel density. Korean J Radiol. 2012 Jan-Feb;13 Suppl 1:S89-97. doi: 10.3348/kjr.2012.13.S1.S89. Epub 2012 Apr 23. Erratum in: Korean J Radiol. 2012 Jul-Aug;13(4):522.</citation>
    <PMID>22563293</PMID>
  </reference>
  <reference>
    <citation>Goh V, Glynne-Jones R. Perfusion CT imaging of colorectal cancer. Br J Radiol. 2014 Feb;87(1034):20130811. doi: 10.1259/bjr.20130811. Review.</citation>
    <PMID>24434157</PMID>
  </reference>
  <reference>
    <citation>Dighe S, Castellano E, Blake H, Jeyadevan N, Koh MU, Orten M, Swift I, Brown G. Perfusion CT to assess angiogenesis in colon cancer: technical limitations and practical challenges. Br J Radiol. 2012 Oct;85(1018):e814-25. doi: 10.1259/bjr/19855447. Epub 2012 Apr 18.</citation>
    <PMID>22514101</PMID>
  </reference>
  <reference>
    <citation>Marley AR, Nan H. Epidemiology of colorectal cancer. Int J Mol Epidemiol Genet. 2016 Sep 30;7(3):105-114. eCollection 2016. Review.</citation>
    <PMID>27766137</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 22, 2018</study_first_submitted>
  <study_first_submitted_qc>February 22, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 28, 2018</study_first_posted>
  <last_update_submitted>February 22, 2018</last_update_submitted>
  <last_update_submitted_qc>February 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Peter Edward Megala</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

